Clinical studies of Norpace (Part VI).
D000328:Adult; D000889:Anti-Arrhythmia Agents / Q000009:adverse effects / Q000627:therapeutic use*; D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use; D001145:Arrhythmias, Cardiac / Q000188:drug therapy*; D001919:Bradycardia / Q000188:drug therapy; D002986:Clinical Trials as Topic; D004206:Disopyramide / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006333:Heart Failure / Q000150:complications; D006801:Humans; D007676:Kidney Failure, Chronic / Q000139:chemically induced; D008134:Long-Term Care; D008297:Male; D010138:Pacemaker, Artificial; D010919:Placebos; D011725:Pyridines / Q000627:therapeutic use*; D013610:Tachycardia / Q000188:drug therapy
D000889:Anti-Arrhythmia Agents; D000925:Anticoagulants; D010919:Placebos; D011725:Pyridines; D004206:Disopyramide